{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:07:12Z","timestamp":1784034432382,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2019201455"],"award-info":[{"award-number":["H2019201455"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2020201018"],"award-info":[{"award-number":["H2020201018"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008047","name":"Hebei University","doi-asserted-by":"publisher","award":["hbu2020ss055"],"award-info":[{"award-number":["hbu2020ss055"]}],"id":[{"id":"10.13039\/501100008047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015286","name":"Hebei Provincial Key Research Projects","doi-asserted-by":"publisher","award":["20372702D"],"award-info":[{"award-number":["20372702D"]}],"id":[{"id":"10.13039\/501100015286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.intimp.2020.107168","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T16:53:13Z","timestamp":1606668793000},"page":"107168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Recent advance of spleen tyrosine kinase in diseases and drugs"],"prefix":"10.1016","volume":"90","author":[{"given":"Yuxin","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107168_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00937","article-title":"Hematopoietic or osteoclast-specific deletion of SYK leads to increased bone mass in experimental mice","author":"Csete","year":"2019","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107168_b0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/13543784.2018.1459562","article-title":"Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia","volume":"27","author":"Bartaula-Brevik","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"22","key":"10.1016\/j.intimp.2020.107168_b0015","first-page":"2283","article-title":"Elevated level of circulatorysTLT1 induces inflammation through SYK\/MEK\/ERK signalling in coronaryartery disease","volume":"133","author":"Das","year":"2019","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.intimp.2020.107168_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/antib6040023","article-title":"Modulation of BCR signaling by the induced dimerization of receptor-associated SYK","volume":"6","author":"Westbroek","year":"2017","journal-title":"Antibodies"},{"issue":"10","key":"10.1016\/j.intimp.2020.107168_b0025","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3748\/wjg.v26.i10.1005","article-title":"Role of spleen tyrosine kinase in liver diseases","volume":"26","author":"Kurniawan","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.intimp.2020.107168_b0030","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/jbmr.3205","article-title":"DOK3 modulates bone remodeling by negatively regulating osteoclastogenesis and positively regulating osteoblastogenesis","volume":"32","author":"Cai","year":"2017","journal-title":"J. Bone Min. Res."},{"issue":"5","key":"10.1016\/j.intimp.2020.107168_b0035","first-page":"1077","article-title":"Genome profiling revealed the activation of IL2RG\/JAK3\/STAT5 in peripheral T-cell lymphoma expressing the ITK-SYK fusion gene","volume":"55","author":"Zhang","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2020.107168_b0040","doi-asserted-by":"crossref","first-page":"E611","DOI":"10.3390\/biom10040611","article-title":"Anti-inflammatory functions of alverine via targeting Src in the NF-\u03baB pathway","author":"Lee","year":"2020","journal-title":"Biomolecules"},{"issue":"S1","key":"10.1016\/j.intimp.2020.107168_b0045","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2020.34.s1.01796","article-title":"Protein-tyrosine kinase, SYK accelerates phagosome maturation by depolymerizing F-actin in complement-mediated phagocytosis","volume":"34","author":"Tabata","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2020.107168_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/507291","article-title":"Regulation and function of SYK tyrosine kinase in mast cell signaling and beyond","volume":"2011","author":"de Castro","year":"2011","journal-title":"J. Signal Transduct."},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev-immunol-042617-053344","article-title":"Multidomain control over TEC kinase activation state tunes the T cell response","volume":"36","author":"Andreotti","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107168_b0060","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/emboj\/17.9.2584","article-title":"A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling","volume":"17","author":"Latour","year":"1998","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.intimp.2020.107168_b0065","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/0008-5472.CAN-13-2104","article-title":"Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma","volume":"74","author":"Hong","year":"2014","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.intimp.2020.107168_b0070","first-page":"4724","article-title":"Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.107168_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2015.02.057","article-title":"Signal transduction and chemotaxis in mast cells","volume":"778","author":"Draber","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"33","key":"10.1016\/j.intimp.2020.107168_b0080","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1073\/pnas.0708583105","article-title":"Tyr130 phosphorylation triggers SYK release from antigen receptor by long-distance conformational uncoupling","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"January","key":"10.1016\/j.intimp.2020.107168_b0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcp.2019.01.008","article-title":"Structural optimization and anti-allergic activity of nucleotide aptamers target to C \u03b5 3-C \u03b5 4","volume":"161","author":"Yang","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107168_b0090","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.coph.2010.05.012","article-title":"Immunotherapy for allergies and asthma: Present and future","volume":"10","author":"Mohapatra","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107168_b0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2018.03.035","article-title":"Furaltadone suppresses IgE-mediated allergic response through the inhibition of Lyn\/Syk pathway in mast cells","volume":"828","author":"Nam","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107168_b0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaci.2018.05.019","article-title":"Autoantibodies to IgE and Fc\u03b5RI and the natural variability of spleen tyrosine kinase expression in basophils","volume":"143","author":"MacGlashan","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107168_b0105","doi-asserted-by":"crossref","first-page":"pii: E546","DOI":"10.3390\/biom10040546","article-title":"Ranunculus bulumei methanol extract exerts anti-inflammatory activity by targeting Src\/SYK in NF-\u03baB signaling","volume":"10","author":"Han","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.intimp.2020.107168_b0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0625.2012.01477.x","article-title":"The role of the TRAF-interacting protein inproliferation and differentiation","volume":"21","author":"Chapard","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2020.107168_b0115","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.alit.2017.06.015","article-title":"Resveratrol inhibits IgE binding and down-regulates intracellular phosphorylation of SYK following IgE aggregation on human basophils","volume":"66","author":"Arakawa","year":"2017","journal-title":"Allergol. Int."},{"issue":"9","key":"10.1016\/j.intimp.2020.107168_b0120","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.tips.2012.06.002","article-title":"IgE-dependent signaling as a therapeutic target for allergies","volume":"33","author":"MacGlashan","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2020.107168_b0125","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/emboj.2008.62","article-title":"The kinase SYK as an adaptor controlling sustained calcium signalling and B-cell development","volume":"27","author":"Kulathu","year":"2008","journal-title":"EMBO J."},{"issue":"May","key":"10.1016\/j.intimp.2020.107168_b0130","article-title":"Sauchinone suppresses Fc\u03b5RI-mediated mast cell signaling and anaphylaxis through regulation of LKB1\/AMPK axis and SHP-1-SYK signaling module","volume":"74","author":"Deng","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"24","key":"10.1016\/j.intimp.2020.107168_b0135","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1016\/j.febslet.2010.08.006","article-title":"Mast cell signaling: The role of protein tyrosine kinase SYK, its activation and screening methods for new pathway participants","volume":"584","author":"Siraganian","year":"2010","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.intimp.2020.107168_b0140","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1074\/jbc.M407805200","article-title":"Molecular basis for a direct interaction between the SYK protein-tyrosine kinase and phosphoinositide 3-kinase","volume":"280","author":"Moon","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2020.107168_b0145","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1073\/pnas.051003498","article-title":"Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling","volume":"98","author":"Lafont","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.intimp.2020.107168_b0150","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.molimm.2009.05.013","article-title":"Fc\u03b5RI-induced activation by low antigen concentrations results in nuclear signals in the absence of degranulation","volume":"46","author":"Grodzki","year":"2009","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107168_b0155","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2010-07-295659","article-title":"SYK regulates B-cell migration by phosphorylation of the F-actin interacting protein SWAP-70","volume":"117","author":"Pearce","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200501111","article-title":"Fc\u03b5RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane","volume":"170","author":"Nishida","year":"2005","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107168_b0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10059-010-0161-5","article-title":"Crystal structures of spleen tyrosine kinase in complex with two novel 4-aminopyrido[4,3-d] pyrimidine derivative inhibitors","volume":"41","author":"Lee","year":"2018","journal-title":"Mol. Cells"},{"issue":"58","key":"10.1016\/j.intimp.2020.107168_b0170","first-page":"9","article-title":"Altered recruitment of Lyn, SYK and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus","volume":"2019","author":"V\u00e1squez","year":"2018","journal-title":"Cell Signal"},{"issue":"7","key":"10.1016\/j.intimp.2020.107168_b0175","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0961203314560424","article-title":"Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus","volume":"24","author":"Iwata","year":"2015","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.intimp.2020.107168_b0180","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.23428","article-title":"An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus","volume":"58","author":"Bahjat","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.intimp.2020.107168_b0185","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/art.27452","article-title":"Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.intimp.2020.107168_b0190","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.4049\/jimmunol.181.11.8145","article-title":"Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells 1","volume":"181","author":"Krishnan","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107168_b0195","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.kint.2019.12.014","article-title":"Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model","volume":"97","author":"McAdoo","year":"2020","journal-title":"Kidney Int."},{"issue":"15","key":"10.1016\/j.intimp.2020.107168_b0200","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.bmc.2018.06.029","article-title":"Discovery of novel SYK\/PDGFR-\u03b1\/c-Kit inhibitors as multi-targeting drugs to treat rheumatoid arthritis","volume":"26","author":"Li","year":"2018","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.intimp.2020.107168_b0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/DDDT.S25426","article-title":"Kinase inhibitors : a new class of antirheumatic drugs","volume":"6","author":"Kyttaris","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2020.107168_b0210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase : a crucial player in diverse biological functions","volume":"10","author":"Kinase M\u00f3csai","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"111","key":"10.1016\/j.intimp.2020.107168_b0215","first-page":"347","article-title":"Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis","volume":"2019","author":"Alzahrani","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"104","key":"10.1016\/j.intimp.2020.107168_b0220","first-page":"1","article-title":"The signaling relations between three adaptors of porcine C-type lectin receptor pathway","volume":"2020","author":"Jiang","year":"2019","journal-title":"Dev. Comp. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107168_b0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.immuni.2005.03.004","article-title":"SYK-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins","volume":"22","author":"Rogers","year":"2005","journal-title":"Immunity"},{"issue":"1\u20133","key":"10.1016\/j.intimp.2020.107168_b0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2012.02.026","article-title":"Arctigenin suppresses receptor activator of nuclear factor \u03ba B ligand (RANKL) -mediated osteoclast differentiation in bone marrow-derived macrophages","volume":"682","author":"Kim","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107168_b0235","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jbmr.3882","article-title":"Alveolar bone protection by targeting the SH3BP2-SYK axis in osteoclasts","volume":"35","author":"Kittaka","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0240","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-065X.2009.00837.x","article-title":"Autoinhibition and adapter function of SYK","volume":"232","author":"Kulathu","year":"2009","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0245","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4049\/jimmunol.1203040","article-title":"The role of the SYK\/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling","volume":"193","author":"Alsadeq","year":"2014","journal-title":"J. Immunol."},{"issue":"43","key":"10.1016\/j.intimp.2020.107168_b0250","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1073\/pnas.1009048107","article-title":"SYK is a dual-specificity kinase that self-regulates the signal output from the B-cell antigen receptor","volume":"107","author":"Heizmann","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.intimp.2020.107168_b0255","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1074\/jbc.RA117.000660","article-title":"Phosphorylated immunoreceptor tyrosine-based activation motifs and integrin cytoplasmic domains activate spleen tyrosine kinase via distinct mechanisms","volume":"293","author":"Antenucci","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2020.107168_b0260","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2011-09-380709","article-title":"CLEC-2 and SYK in the megakaryocytic\/platelet lineage are essential for development","volume":"119","author":"Finney","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.intimp.2020.107168_b0265","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1182\/blood-2014-05-572818","article-title":"CLEC-2 expression is maintainedon activated platelets and on platelet microparticles","volume":"124","author":"Gitz","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2020.107168_b0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbamcr.2011.10.001","article-title":"The protein-tyrosine kinase SYK interacts with the C-terminal region of tensin2","volume":"1823","author":"Moon","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"14","key":"10.1016\/j.intimp.2020.107168_b0275","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.18632\/oncotarget.27545","article-title":"Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells","volume":"11","author":"Lamb","year":"2020","journal-title":"Oncotarget."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2020.107168_b0280","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1158\/1538-7445.AM2017-4204","article-title":"A novel dual SYK\/JAK inhibitor with strong antitumor activity in both hematological and solid tumor xenograft models [abstract]","volume":"77","author":"Reddy","year":"2017","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2020.107168_b0285","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.tranon.2019.04.023","article-title":"IL-17A increases multiple myeloma cell viability by positively regulating SYK expression","volume":"12","author":"Wang","year":"2019","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0290","doi-asserted-by":"crossref","first-page":"742","DOI":"10.18632\/oncotarget.13557","article-title":"Inhibition of BCR signaling using the SYK inhibitor TAK-659 prevents stroma-mediated signaling in chroniclymphocytic leukemia cells","volume":"8","author":"Purroy","year":"2017","journal-title":"Oncotarget."},{"issue":"5","key":"10.1016\/j.intimp.2020.107168_b0295","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/jcmm.14927","article-title":"Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia","volume":"24","author":"Weisberg","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"8","key":"10.1016\/j.intimp.2020.107168_b0300","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/s41416-020-0731-z","article-title":"Inhibition of the deubiquitinase USP10 induces degradation of SYK","volume":"122","author":"Yang","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2020.107168_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1005432","article-title":"Reconstruction and signal propagation analysis of the SYK signaling network in breast cancer cells","volume":"13","author":"Naldi","year":"2017","journal-title":"PLoS Comput. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107168_b0310","first-page":"e0185607","article-title":"High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negativecolon cancer patients","volume":"12","author":"Kloosterman","year":"2017","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.intimp.2020.107168_b0315","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/onc.2008.493","article-title":"The protein-tyrosine kinase SYK interacts with TRAF-interacting protein TRIP in breast epithelial cells","volume":"28","author":"Zhou","year":"2009","journal-title":"Oncogene"},{"issue":"101","key":"10.1016\/j.intimp.2020.107168_b0320","first-page":"3","article-title":"Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer","volume":"2020","author":"Black","year":"2019","journal-title":"Oral. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15568-2","article-title":"Timescale separation of positive andnegative signaling creates history-dependent responses to IgE receptor stimulation","volume":"7","author":"Harmon","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2020.107168_b0330","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1139\/cjpp-2017-0307","article-title":"SYK inhibitor R406 down-regulates inflammation in an in vitro model of Pseudomonas aeruginosa infection","volume":"96","author":"Alhazmi","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0335","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.anai.2019.08.014","article-title":"New treatments for chronic urticaria","volume":"124","author":"Kolkhir","year":"2020","journal-title":"Ann Allergy, Asthma Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107168_b0340","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2019.10.005","article-title":"New treatments for atopic dermatitis targeting beyond IL-4\/IL-13 cytokines","volume":"124","author":"Renert-Yuval","year":"2020","journal-title":"Ann Allergy, Asthma Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107168_b0345","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00262-016-1946-y","article-title":"The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients","volume":"66","author":"Colado","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.intimp.2020.107168_b0350","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1124\/jpet.111.188441","article-title":"Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis","volume":"340","author":"Coffey","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2020.107168_b0355","doi-asserted-by":"crossref","first-page":"pii: E1974","DOI":"10.3390\/cancers11121974","article-title":"The SYK kinase promotes mammary epithelial integrity and inhibits breast cancer invasion by stabilizing the E-cadherin\/catenin complex","volume":"11","author":"Kassouf","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.intimp.2020.107168_b0360","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaci.2019.10.005","article-title":"Identifying regulatory pathways of spleen tyrosine kinase expression in human basophils","volume":"145","author":"Peng","year":"2020","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920336353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:47:27Z","timestamp":1762552047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920336353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":72,"alternative-id":["S1567576920336353"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107168","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advance of spleen tyrosine kinase in diseases and drugs","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107168"}}